Literature DB >> 16865051

HIV and syphilis: when to perform a lumbar puncture.

Agnès Libois1, Stéphane De Wit, Bénédicte Poll, Felipe Garcia, Eric Florence, Ana Del Rio, Paquita Sanchez, Eugenia Negredo, Marc Vandenbruaene, José M Gatell, Nathan Clumeck.   

Abstract

OBJECTIVES: The objectives of this study were to determine predictive factors for neurosyphilis in HIV-infected patients with syphilis and optimize the use of lumbar puncture. STUDY
DESIGN: The authors reviewed 112 cases of HIV-infected patients with syphilis who underwent a lumbar puncture. Diagnosis of neurosyphilis was based on a cerebrospinal fluid white blood cells count > or =20/microL, and/or a reactive cerebrospinal fluid-Venereal Disease Research Laboratory, and/or a positive intrathecal T. pallidum antibody (ITPA) index.
RESULTS: Twenty-six of 112 had neurosyphilis. Neurologic manifestations and serum rapid plasma reagin (RPR) were associated with neurosyphilis (P = 0.036, P = 0.018, respectively). In multivariate analysis, log(2)RPR was still associated with neurosyphilis (P = 0.005). In patients without neurologic manifestations, the risk of neurosyphilis increases gradually with log(2)RPR. A serum RPR of 1/32 seems to be the best cutoff point to decide the performance or not of a lumbar puncture (sensitivity 100%, specificity 40%).
CONCLUSION: In HIV-infected patients with syphilis, lumbar puncture could be restricted to those with neurologic manifestations or a serum RPR > or =1/32.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16865051     DOI: 10.1097/01.olq.0000230481.28936.e5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  37 in total

Review 1.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.

Authors:  Christina M Marra; Lauren C Tantalo; Clare L Maxwell; Emily L Ho; Sharon K Sahi; Trudy Jones
Journal:  Sex Transm Dis       Date:  2012-06       Impact factor: 2.830

3.  Update on neurosyphilis.

Authors:  Christina M Marra
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

4.  Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Authors:  Christina M Marra; Lauren C Tantalo; Sharon K Sahi; Shelia B Dunaway; Sheila A Lukehart
Journal:  J Infect Dis       Date:  2015-12-09       Impact factor: 5.226

5.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 6.  Recent trends in the serologic diagnosis of syphilis.

Authors:  Muhammad G Morshed; Ameeta E Singh
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 7.  What's new in sexually transmitted infections in the HIV care setting: focus on syphilis and gonorrhea.

Authors:  Jeanne M Marrazzo
Journal:  Top Antivir Med       Date:  2014 Dec-2015 Jan

Review 8.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

Review 9.  Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men.

Authors:  Chelsea P Roberts; Jeffrey D Klausner
Journal:  Expert Rev Anti Infect Ther       Date:  2016-09-23       Impact factor: 5.091

10.  Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms.

Authors:  Khalil G Ghanem; Richard D Moore; Anne M Rompalo; Emily J Erbelding; Jonathan M Zenilman; Kelly A Gebo
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.